Videos

CBT and fluoxetine both reduced pediatric anxiety, while starting with CBT before adding medication showed advantages on several outcomes.

Pediatric psychiatric diagnoses and treatment rose above prepandemic levels, with notable increases in medication initiation and care among girls.

Pediatric mental health treatment exceeded prepandemic levels, with antidepressant initiation rising sharply among girls after COVID-19.

John Walkup, MD, says collaborative care, education, and psychiatric consultation can help pediatricians manage children's mental health needs.

John Walkup, MD, says pediatricians can address growing mental health needs by identifying risk factors and providing guidance early in childhood.

Lisa Swanson, MD, describes AD as fundamentally unpredictable — a roller coaster of flares and quiet stretches that can wear down patients and families alike.

Lisa Swanson, MD, returns to diagnostic pitfalls, describing a presentation she sees often: AD in the crease of an infant's neck, which is frequently misdiagnosed as a yeast infection.

Permanent daylight saving time could affect pediatric sleep, with later evening light posing particular concerns for children and adolescents.

Permanent daylight saving time could disrupt children's circadian rhythms, affecting sleep, school performance, mood, and morning safety.

Ravi Jhaveri, MD, says proposed changes to the childhood vaccine schedule lack evidence and could leave vulnerable children unprotected.

Lori Handy, MD, says vaccine conversations with hesitant families should prioritize trust, follow-up, and the benefits for the individual child.

Lori Handy, MD, says back-to-school visits give pediatricians an opportunity to revisit vaccines and address questions families encounter online.

Lisa Swanson, MD, addresses the practical barriers pediatricians face when trying to refer a patient with AD.

Lisa Swanson, MD, lays out the current JAK inhibitor landscape for pediatric AD.

Phase 3 SMART data support the safety of clesrovimab in infants and children at increased risk for severe RSV disease across 2 seasons.

A pediatric pain specialist says a dedicated procedure suite helps deliver faster, more individualized chronic pain care while restoring function.

Phase 3 SMART trial found clesrovimab was well tolerated in high-risk infants through 2 RSV seasons, with safety comparable to palivizumab.

A pediatric pain specialist says multidisciplinary care and family engagement are key to restoring function in children with chronic pain.

A collaborative mental health program increased pediatricians' diagnosis, follow-up, and treatment of anxiety and depression in primary care.

A pediatric pain specialist says multidisciplinary care and family engagement are key to restoring function in children with chronic pain.

An interventional pain specialist says pediatricians can improve outcomes by recognizing chronic pain early and referring children before disability worsens.

Lisa Swanson, MD, acknowledges that the decision to refer a patient with AD to a dermatologist or allergist is highly individualized, shaped by each pediatric clinician's own comfort level with skin disease.

Lisa Swanson, MD, describes the framework she uses at follow-up visits to judge whether a topical steroid regimen is succeeding.

Lisa Swanson, MD, narrows in on severity assessment tools that are actually practical for a busy pediatrics office, as opposed to the more elaborate scales used in clinical trials.

A scaly patch on a baby's scalp could be cradle cap — or the first sign of a lifelong condition. Lisa Swanson, MD, walks through the exact clues that tell the two apart.

A California study found rising pediatric e-bike injuries, prompting calls for pediatricians to counsel families on safe riding and helmet use.

Pediatric psychologist Jeff Temple, PhD, says healthy routines, parental modeling, and child maturity matter more than screen time alone.

Temple recommends structured back-to-school routines and intentional screen use instead of strict limits to support child well-being.

Olivia Kim-McManus, MD, discusses how personalized antisense therapy reduced seizures and improved development in 2 children with SCN2A-related developmental epileptic encephalopathy.

Joyce Woo, MD, says timely diagnosis, coordinated transfer, and early surgical planning may improve care for newborns with severe congenital heart defects.